CCL2 and Parkinson disease: Parkinson’s Disease pathogenesis is also thought to involve down-regulation of nuclear receptor Nurr1 in microglia and astrocytes, leading to increased production of mediators such as chemokine CCL2 that may promote apoptosis of dopaminergic neurons (Liu et al., 2017).